September 26, 2008 - CryoCath Technologies Inc. announced yesterday it has resolved all outstanding patent suits among the company and Boston Scientific Corp., its wholly-owned subsidiary, CryoCor Inc., and CryoCor's co-plaintiff/co-defendant AMS Research Corp.

September 26, 2008 - Boston Scientific Corp. today announced the grand opening of the International Institute for Therapy Advancement in Paris, dedicated to providing world-class training and education to help healthcare professionals advance the standard of patient care.
The 3,000 square-meter facility is said to offer the latest in modern medical training and current clinical science focused on cardiac and vascular therapies.

September 26, 2008 - The 6th annual Medical Innovation Summit at Cleveland Clinic is scheduled for Nov. 10-12 in Cleveland, OH.

More than 900 senior executives, investors, entrepreneurs and clinicians are expected to attend.

The summit will feature:

- Detailed insights into the newest innovations in the fast growing urology and gynecology markets including live, interactive surgery

- “Top 10” medical innovations for 2009

- Analysis on new directions for supporting innovation

For more information: www.clevelandclinic.org/innovations/summit/

Carestream Health's SuperPACS architecture allows healthcare providers to efficiently connect disparate PACS at multiple sites throughout a healthcare system.

September 25, 2008 - Boston Scientific Corp. announced it has received approval from the FDA to market its TAXUS Express2 Atom paclitaxel-eluting coronary stent system, a drug-eluting stent (DES) specifically designed for treating small coronary vessels.

The TAXUS Express2 Atom Stent System is the only DES approved by the FDA for use in vessels as small as 2.25 mm in diameter, stated Boston Scientific.

September 25, 2008 - The Global Markets for Cardiac Rhythm Management (CRM) Devices 2009 report by Millennium Research Group (MRG) shows the CRM device market has recovered after a slump caused by several device recalls that began in 2005, and that the market will continue its recovery and growth over the next five years due largely to implantable defibrillator sales, which include implantable cardioverter defibrillators (ICDs) and cardiac resynchronization therapy defibrillators (CRT-Ds).

September 25, 2008- The use of the CVRx Rheos System in treating early-stage heart failure patients shows Rheos Therapy significantly improved heart structure and function, according to clinical data presented this week by John D. Bisognano, M.D, Ph.D., associate professor of medicine at the University of Rochester School of Medicine and Dentistry, New York, at the Heart Failure Society of America (HFSA) 12th Annual Scientific Meeting in Toronto.

September 23, 2008 – In response to the FDA approval of Covidien’s ANDA for generic Kit for the Preparation of Technetium Tc99m Sestamibi Injection, Lantheus Medical Imaging said it will compete with competitive pricing.

September 24, 2008 - Philips Research and the University of Urbino (Urbino, Italy) this week signed a research agreement to study the encapsulation of magnetic nanoparticle contrast agents inside living blood cells to prolong the retention time of these agents in the blood.

September 24, 2008 - GE Healthcare’s satisfaction scores reflect significant improvements in customer perceptions of service quality in both MD Buyline’s second quarter 2008 customer satisfaction survey and IMV ServiceTrak’s 2008 report.

MD Buyline and ServiceTrak present independent analysis of service trends in industry and manufacturer ratings within each modality.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now